214759-66-7

Basic information

• Product Name: METHYL 3-CHLORO-4-CYANOBENZOATE
• Synonyms: METHYL 3-CHLORO-4-CYANOBENZOATE;3-Chloro-4-cyano-benzoic acid Methyl ester;2-Chloro-4-(methoxycarbonyl)benzonitrile
• CAS NO: 214759-66-7
• Molecular Formula: C₉H₆ClNO₂
• Molecular Weight: 195.60244
• EINECS: 200-589-5
• Mol File: 214759-66-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: METHYL 3-CHLORO-4-CYANOBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-CHLORO-4-CYANOBENZOATE(214759-66-7)
• EPA Substance Registry System: METHYL 3-CHLORO-4-CYANOBENZOATE(214759-66-7)

Safety Data

• Hazardous Substances Data: 214759-66-7(Hazardous Substances Data)

Usage

General Description

Methyl 3-chloro-4-cyanobenzoate is an organic compound with the chemical formula C9H6ClNO2. It is a white crystalline solid that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. METHYL 3-CHLORO-4-CYANOBENZOATE is widely used in the pharmaceutical industry for the production of various medicines, and in the agricultural industry for the production of pesticides. Methyl 3-chloro-4-cyanobenzoate is also used as a building block in organic synthesis, and as a reagent in chemical research. It is important to handle this compound with care, as it may pose health and environmental hazards.

InChI:InChI=1S/C9H6ClNO2/c1-13-9(12)6-2-3-7(5-11)8(10)4-6/h2-4H,1H3

Upstream product

• 84228-44-4 methyl 4-amino-3-chlorobenzoate 
• 117738-74-6 methyl 4-bromo-3-chlorobenzoate 
• 371764-70-4 2-chloro-4-iodobenzonitrile 

Downstream Products

• 371766-31-3 5-[benzyl-(1-trityl-1H-imidazol-4-ylmethyl)-amino]-2'-methyl-biphenyl-2-carbonitrile 
• 565451-82-3 2'-methyl-5-[(1-trityl-1H-imidazol-4-ylmethyl)-amino]-biphenyl-2-carbonitrile 
• 371763-66-5 4-(((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)benzonitrile 
• 371765-74-1 4-carboxy-2-(1-naphthyl)benzonitrile 
• 371766-01-7 4-amino-2-(1-naphthyl)benzonitrile 

Relevant articles and documents

BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RARβ) AGONISTS

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain bicycloheteroaryl-heteroaryl-benzoic acid compounds of the following formula (for convenience, collectively referred to herein as "BHBA compou

Farnesyltransferase inhibitors

Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.

Substituted phenyl farnesyltransferase inhibitors

Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.